Skip to main content

Test Price

2,800 AED

✅ Home Collection Available

SAMD9 Gene Mirage Syndrome Genetic Test in UAE – 2800 AED – DHA Licensed

Executive Summary & Core Metrics

Clinical-Grade Precision: This NGS test analyzes the entire SAMD9 coding region for pathogenic variants linked to Mirage syndrome, delivering 99.9% diagnostic sensitivity under ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139).

  • Accuracy Guarantee: Gold-standard Illumina sequencing with CNV detection.
  • Premium Logistics: ISO-certified cold-chain home collection (finger-prick or venous).
  • Complimentary Guidance: Post-test telephonic clinical correlation session.
  • Insurance Verification: Direct billing via WhatsApp +971 54 548 8731.

Test Overview & Methodology

The SAMD9 Gene Mirage Syndrome NGS Test employs Next-Generation Sequencing to interrogate all coding exons and flanking splice sites of the SAMD9 gene for single nucleotide variants, small indels, and copy number variations. It is the gold standard for confirming a clinical diagnosis of Mirage syndrome, a rare multisystem disorder characterized by myelodysplasia, adrenal insufficiency, growth retardation, and genital anomalies.

Feature Our Test (Premium) Closest Alternative
Precision Full gene sequencing + CNV detection (100x coverage) Sanger sequencing of selected exons only
Methodology Illumina NGS with advanced bioinformatics Capillary electrophoresis – misses large deletions
Turnaround 3–4 Weeks 4–6 Weeks

Physician Insight & Safety Protocols

Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA Registration ID: 9294403

My team and I recognise the profound anxiety that accompanies genetic testing for rare paediatric syndromes. This test provides answers that can guide precise management, but it is only one element of care—your child’s ongoing clinical supervision remains paramount. If the result reveals a pathogenic variant, our genetic counsellors will immediately coordinate specialist referrals and family screening to ensure no family member is left uninformed.

Medication Safety Advisory

Do not discontinue prescribed medication without consulting your doctor.

Exclusion Criteria & Emergency Red Flags

  • Exclusion: Recent blood transfusion (<2 weeks) or active haemolysis—may compromise DNA yield.
  • Immediate Emergency: If your child develops high fever with severe infection, unusual bleeding/bruising, or signs of adrenal crisis (vomiting, shock, lethargy), seek urgent medical care. Do not wait for genetic results.
  • Informed Consent: A pre‑test genetic counselling session and pedigree chart are mandatory per UAE clinical guidelines.

Patient FAQ & Clinical Guidance

1. What is the clinical utility of the SAMD9 gene test?

This NGS-based test definitively diagnoses Mirage syndrome by detecting pathogenic SAMD9 mutations, enabling tailored management and familial risk stratification. It helps differentiate Mirage from other bone marrow failure syndromes and informs decisions regarding haematopoietic stem cell transplantation.

2. How is the sample collected and what is the turnaround time?

Collection requires only one drop of blood on an FTA card or a standard venous draw, performed at home by our DHA-licensed phlebotomists between 8 AM and 11 PM. The sample is transported under strict cold‑chain conditions, and your comprehensive report is available within 3 to 4 weeks.

3. Is insurance accepted and how do I verify coverage?

Yes, we process direct billing with all major UAE insurers—simply WhatsApp your policy card to +971 54 548 8731 for instant verification. Our team will confirm pre‑approval within two hours, and you only pay any applicable co‑insurance after that.

UAE Regulatory & Data Privacy Adherence

Data Security: All genetic data are processed in compliance with UAE Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability.

DHA Facility License: 1143 | Corporate Lab: DNA Labs UAE | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE.

Clinical & Logistical Metadata

Test Name SAMD9 Gene Mirage Syndrome Genetic Test
Price (AED) 2,800 AED
Turnaround Time 3–4 Weeks
Sample Type / Matrix Peripheral Blood (FTA card or venous draw) – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily 8 AM–11 PM
Methodology Used Next-Generation Sequencing (Illumina platform) – Full coding region + CNV analysis
ICD-10-CM Code Q87.89 (Mirage syndrome), D46.9 (Myelodysplastic syndrome), Z15.89 (Genetic susceptibility)
LOINC Code 93390-1 (SAMD9 gene full mutation analysis)
DHA Facility License & Address License No. 1143 | DNA Labs UAE | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians